We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 18, 2019

Initiation of Angiotensin–Neprilysin Inhibition After Acute Decompensated Heart Failure

JAMA Cardiology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Cardiology
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-Label Extension of the PIONEER-HF Trial
JAMA Cardiol 2019 Dec 11;[EPub Ahead of Print], AD DeVore, E Braunwald, DA Morrow, CI Duffy, AP Ambrosy, H Chakraborty, K McCague, R Rocha, EJ Velazquez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading